Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Short term Debt (2021 - 2025)

Bioregenx (BRGX) has 5 years of Short term Debt data on record, last reported at $880796.0 in Q1 2025.

  • For Q1 2025, Short term Debt changed N/A year-over-year to $880796.0; the TTM value through Mar 2025 reached $880796.0, changed N/A, while the annual FY2024 figure was $883271.0, 135.11% up from the prior year.
  • Short term Debt reached $880796.0 in Q1 2025 per BRGX's latest filing, roughly flat from $883271.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $883271.0 in Q4 2024 and bottomed at $2163.0 in Q4 2021.
  • Average Short term Debt over 5 years is $358883.7, with a median of $200000.0 recorded in 2023.
  • Peak YoY movement for Short term Debt: surged 93.67% in 2022, then surged 8868.27% in 2023.
  • A 5-year view of Short term Debt shows it stood at $2163.0 in 2021, then surged by 93.67% to $4189.0 in 2022, then soared by 8868.27% to $375681.0 in 2023, then soared by 135.11% to $883271.0 in 2024, then dropped by 0.28% to $880796.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Short term Debt were $880796.0 in Q1 2025, $883271.0 in Q4 2024, and $875475.0 in Q3 2024.